Joinn Laboratories (China) Co (HKSE:06127) Net Margin % : 20.47% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Joinn Laboratories (China) Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Joinn Laboratories (China) Co's Net Income for the three months ended in Sep. 2024 was HK$109 Mil. Joinn Laboratories (China) Co's Revenue for the three months ended in Sep. 2024 was HK$535 Mil. Therefore, Joinn Laboratories (China) Co's net margin for the quarter that ended in Sep. 2024 was 20.47%.

The historical rank and industry rank for Joinn Laboratories (China) Co's Net Margin % or its related term are showing as below:

HKSE:06127' s Net Margin % Range Over the Past 10 Years
Min: -0.04 Med: 26.51 Max: 47.37
Current: -0.04

HKSE:06127's Net Margin % is ranked better than
59.53% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.68 vs HKSE:06127: -0.04

Joinn Laboratories (China) Co Net Margin % Historical Data

The historical data trend for Joinn Laboratories (China) Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co Net Margin % Chart

Joinn Laboratories (China) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

29.21

29.28

36.76

47.37

16.71

Joinn Laboratories (China) Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Margin %	Get a 7-Day Free Trial															41.21	8.79	-83.81	19.54	20.47

Competitive Comparison of Joinn Laboratories (China) Co's Net Margin %

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Joinn Laboratories (China) Co's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's Net Margin % falls into.

Joinn Laboratories (China) Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Joinn Laboratories (China) Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	434.223	/	2599.351
	=	16.71 %

Joinn Laboratories (China) Co's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin	=	Net Income (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	109.484	/	534.888
	=	20.47 %

Joinn Laboratories (China) Co (HKSE:06127) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Joinn Laboratories (China) Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Joinn Laboratories (China) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (HKSE:06127) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

603127:China

Address

A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176

Website

https://www.joinnlabs.com

Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

Executives

Futu Trustee Limited	2301 Trustee
Ubs Group Ag	2201 Interest of corporation controlled by you
Aggregate Of Abrdn Plc Affiliated Investment Management Entities	2102 Investment manager
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co.	2502 Approved lending agent
Fidelity Funds	2101 Beneficial owner
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Abrdn Asia Focus Plc	2101 Beneficial owner
Morgan Stanley	2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc.	2201 Interest of corporation controlled by you
Apg Asset Management N.v.	2101 Beneficial owner
Apg Groep N.v.	2101 Beneficial owner
Stichting Pensioenfonds Abp	2101 Beneficial owner

Joinn Laboratories (China) Co Headlines

No Headlines